They also enhance patient outcomes, particularly for those with type 2 diabetes mellitus (T2DM) and cardiovascular disease, by reducing severe adverse cardiovascular complications
As a result, your blood sugar levels may change, and you may not experience the same benefits in managing your diabetes
Perfect B Aesthetic Medicine | 06.24.26 | 5 min read
Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats
In DECLARE-TIMI58 with dapagliflozin, 4.4% of the patients were using GLP-1RAs at baseline, and dapagliflozin reduced the risks of MACE, HHF, and composite kidney outcomes regardless of baseline GLP-1RA use [49]